Mo1093 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, DEMONSTRATES EFFICACY IN PATIENT-DERIVED PBMC IN VITRO AND IN AN IN VIVO T CELL TRANSFER MODEL OF CHRONIC INFLAMMATORY BOWEL DISEASE (IBD)
Dillon, Stacey R., Evans, Lawrence S., Bort, Susan, Mudri, Sherri, Lewis, Katherine, Rixon, Mark, Bhandari, Janhavi, Peng, Stanford, Swiderek, Kristine M.Volume:
158
Journal:
Gastroenterology
DOI:
10.1016/s0016-5085(20)32636-6
Date:
May, 2020
File:
PDF, 312 KB
2020
File converter
More search results
More benefits 
